Pharmacogenomic technologies: a necessary "luxury" for better global public health?

Pharmacogenomic technologies: a necessary "luxury" for better global public health?

<p>Abstract</p> <p>Background</p> <p>Pharmacogenomic technologies aim to redirect drug development to increase safety and efficacy of individual care. There is much hope that their implementation in the drug development process will help respond to population health nee...

Full description

Bibliographic Details
Main Authors: Williams-Jones Bryn, Olivier Catherine
Format: Article
Language:English
Published: BMC 2011-08-01
Series:Globalization and Health
Subjects:
Pharmacogenomic technologies
drug development
health innovations
global
public health
developing world populations
University of Toronto Joint Centre for Bioethics criteria
inequity
luxury
Online Access:http://www.globalizationandhealth.com/content/7/1/30

Internet

http://www.globalizationandhealth.com/content/7/1/30

Similar Items